Milosevic Katarina, Milosevic Ana, Stevanovic Ivana, Zivkovic Anica, Laketa Danijela, Janjic Marija M, Bjelobaba Ivana, Lavrnja Irena, Savic Danijela
Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic"-National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, Belgrade, Serbia.
Biofactors. 2025 Jan-Feb;51(1):e2149. doi: 10.1002/biof.2149.
Modulating metabolic pathways in activated microglia can alter their phenotype, which is relevant in uncontrolled neuroinflammation as a component of various neurodegenerative diseases. Here, we investigated how pretreatment with agmatine, an endogenous polyamine, affects metabolic changes in an in vitro model of neuroinflammation, a murine microglial BV-2 cell line exposed to lipopolysaccharide (LPS). Hence, we analyzed gene expression using qPCR and protein levels using Western blot and ELISA. Microglial metabolic status was assessed by measuring lactate release and cellular ATP by enzymatic and luminescence spectrophotometry. Mitochondrial functionality was analyzed by fluorescent probes detecting mitochondrial membrane potential (mtMP) and superoxide production. Our findings suggest that kinase pathways associated with hypoxia-inducible factor-1α (HIF-1α) regulate energy metabolism in pro-inflammatory activated microglia. We have shown that LPS induces HIF-1α and genes for glucose transporter and glycolytic rate, increases lactate production and causes mitochondrial dysfunction, suggesting a metabolic shift towards glycolysis. Agmatine inhibits the PI3K/Akt pathway and negatively regulates mammalian target of rapamycin (mTOR) phosphorylation and HIF-1α levels, reducing lactate and tumor necrosis factor (TNF) production, which is supported by pharmacological blockade of PI3K. Pretreatment with agmatine also rescues mitochondrial function by counteracting the LPS-induced decline in mtMP and increase in mitochondrial superoxide, resulting in an anti-apoptotic effect. Agmatine alone increases intracellular ATP levels and maintains this effect even under pro-inflammatory conditions. Our study emphasizes the ability of agmatine to engage in metabolic reprogramming of pro-inflammatory microglia through increased ATP production and modulation of signaling pathway involved in promoting glycolysis and cytokine release.
调节活化小胶质细胞中的代谢途径可以改变其表型,这在作为各种神经退行性疾病组成部分的失控性神经炎症中具有重要意义。在此,我们研究了内源性多胺胍丁胺预处理如何影响神经炎症体外模型中的代谢变化,该模型是暴露于脂多糖(LPS)的小鼠小胶质细胞BV-2细胞系。因此,我们使用qPCR分析基因表达,并使用蛋白质印迹法和酶联免疫吸附测定法分析蛋白质水平。通过酶促和发光分光光度法测量乳酸释放和细胞ATP来评估小胶质细胞的代谢状态。通过检测线粒体膜电位(mtMP)和超氧化物产生的荧光探针分析线粒体功能。我们的研究结果表明,与缺氧诱导因子-1α(HIF-1α)相关的激酶途径调节促炎性活化小胶质细胞中的能量代谢。我们已经表明,LPS诱导HIF-1α以及葡萄糖转运蛋白和糖酵解速率的基因,增加乳酸产生并导致线粒体功能障碍,提示代谢向糖酵解转变。胍丁胺抑制PI3K/Akt途径并负向调节雷帕霉素哺乳动物靶标(mTOR)磷酸化和HIF-1α水平,减少乳酸和肿瘤坏死因子(TNF)产生,PI3K的药理学阻断支持这一点。胍丁胺预处理还通过抵消LPS诱导的mtMP下降和线粒体超氧化物增加来挽救线粒体功能,从而产生抗凋亡作用。单独使用胍丁胺可增加细胞内ATP水平,即使在促炎条件下也能维持这种作用。我们的研究强调了胍丁胺通过增加ATP产生以及调节参与促进糖酵解和细胞因子释放的信号通路来对促炎性小胶质细胞进行代谢重编程的能力。